SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer

NCT02870153 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Neoplasm

Interventions

DRUG: SOX
DRUG: XELOX

Sponsor

The First People's Hospital of Changzhou